S21-417 Use of Dopaminergic Prodrug to Prevent Myopia Progression Researchers at Stanford have established the safety and penetrance of the dopaminergic prodrug etilevodopa to prevent the progression of myopia ("nearsightedness"). In the past 50 years, myopia prevalence in the U.S. Ira Schachar Cassie Ludwig Stephen Smith